REFERENCES
1. Lyons SK, Plenker D, Trotman LC. Advances in preclinical evaluation of experimental antibody-drug conjugates. Cancer Drug Resist 2021;4:745-54.
2. Venkatesh C, Shen J, Putt KS, Low PS. Evaluation of the reducing potential of PSMA-containing endosomes by FRET imaging. Cancer Drug Resist 2021;4:745-54.
3. Conroy M, Cowzer D, Kolch W, Duffy AG. Emerging RAS-directed therapies for cancer. Cancer Drug Resist 2021;4:543-58.
4. Bijnsdorp IV, Peters GJ. Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro. Cancer Drug Resist 2021;4:719-27.
